COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 2854: Articles 28531-28540  | Next

SARS-CoV-2 receptor mutation in Egyptian population
Abouelhoda, M., Zekri, A.-R. N., Hafez, M. M.
10.1101/2020.04.27.20082206 — Posted: 2020-05-02
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
Garcia-Basteiro, A. L., Moncunill, G., Tortajada, M., Vidal, M., Guinovart, C., Jimenez, A., Santano, R., Sanz, S., Mendez, S., Llupia, A., Aguilar, R., Alonso, S., Barrios, D., Carolis, C., Cistero, P., Choliz, E., Cruz, A., Fochs, S., Jairoce, C., Hecht, J., Lamoglia, M., Martinez, M. J., Mitchell, R., Ortega, N., Pey, N., Puyol, L., Ribes, M., Rosell, N., Sotomayor, P., Torres, S., Williams, S., Barroso, S., Vilella, A., Munoz, J., Varela, P., Trilla, A., Mayor, A., Dobano, C.
10.1101/2020.04.27.20082289 — Posted: 2020-05-02
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study
Mallat, J., Hamed, F., Balkis, M., Mohamed, M. A., Mooty, M., Malik, A., Nusair, A., Bonilla, F.
10.1101/2020.04.27.20082180 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Race, Socioeconomic Deprivation, and Hospitalization for COVID-19 in English participants of a National Biobank
Patel, A. P., Paranjpe, M. D., Kathiresan, N. P., Rivas, M. A., Khera, A. V.
10.1101/2020.04.27.20082107 — Posted: 2020-05-02
Using Supervised Machine Learning and Empirical Bayesian Kriging to reveal Correlates and Patterns of COVID-19 Disease outbreak in sub-Saharan Africa: Exploratory Data Analysis
Onovo, A. A., Atobatele, A., Kalaiwo, A., Obanubi, C., James, E., Gado, P., Odezugo, G., Magaji, D., Ogundehin, D., Russell, M.
10.1101/2020.04.27.20082057 — Posted: 2020-05-02
Chinese effective control and other countries uncharted challenge against COVID-19: an epidemiological and modelling study
Zheng, L., Qin, K., Chen, X., Huang, S., Liu, D., Liao, W., Xia, H., Tang, J., Liang, H.
10.1101/2020.04.28.20083899 — Posted: 2020-05-02
Excess mortality during COVID-19 in five European countries and a critique of mortality analysis data
Felix-Cardoso, J., Vasconcelos, H., Rodrigues, P., Cruz-Correia, R.
10.1101/2020.04.28.20083147 — Posted: 2020-05-02
Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank
Ho, F. K., Celis-Morales, C. A., Gray, S. R., Katikireddi, S. V., Niedzwiedz, C. L., Hastie, C., Lyall, D. M., Ferguson, L. D., Berry, C., Mackay, D. F., Gill, J. M. R., Pell, J. P., Sattar, N., Welsh, P. I.
10.1101/2020.04.28.20083295 — Posted: 2020-05-02
Modeling and Dynamics in Epidemiology, COVID19 withLockdown and Isolation Effect : Application to Moroccan Case
YAFIA, R.
10.1101/2020.04.29.20084871 — Posted: 2020-05-02
How and when to end the COVID-19 lockdown: an optimisation approach
Rawson, T., Brewer, T., Veltcheva, D., Huntingford, C., Bonsall, M. B.
10.1101/2020.04.29.20084517 — Posted: 2020-05-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).